These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
427 related items for PubMed ID: 11950921
1. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations. Demunter A, Libbrecht L, Degreef H, De Wolf-Peeters C, van den Oord JJ. Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921 [Abstract] [Full Text] [Related]
2. Cytoplasmic and nuclear accumulation of beta-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma. Omholt K, Platz A, Ringborg U, Hansson J. Int J Cancer; 2001 Jun 15; 92(6):839-42. PubMed ID: 11351304 [Abstract] [Full Text] [Related]
3. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential. Murakami T, Toda S, Fujimoto M, Ohtsuki M, Byers HR, Etoh T, Nakagawa H. Biochem Biophys Res Commun; 2001 Oct 19; 288(1):8-15. PubMed ID: 11594745 [Abstract] [Full Text] [Related]
4. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features. Odajima T, Sasaki Y, Tanaka N, Kato-Mori Y, Asanuma H, Ikeda T, Satoh M, Hiratsuka H, Tokino T, Sawada N. Hum Pathol; 2005 Mar 19; 36(3):234-41. PubMed ID: 15791567 [Abstract] [Full Text] [Related]
5. Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma. Sugimachi K, Taguchi K, Aishima S, Tanaka S, Shimada M, Kajiyama K, Sugimachi K, Tsuneyoshi M. Mod Pathol; 2001 Sep 19; 14(9):900-5. PubMed ID: 11557787 [Abstract] [Full Text] [Related]
6. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. Wu R, Zhai Y, Fearon ER, Cho KR. Cancer Res; 2001 Nov 15; 61(22):8247-55. PubMed ID: 11719457 [Abstract] [Full Text] [Related]
7. Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma. Maelandsmo GM, Holm R, Nesland JM, Fodstad Ø, Flørenes VA. Clin Cancer Res; 2003 Aug 15; 9(9):3383-8. PubMed ID: 12960126 [Abstract] [Full Text] [Related]
8. No evidence for involvement of beta-catenin and APC in urothelial carcinomas. Stoehr R, Krieg RC, Knuechel R, Hofstaedter F, Pilarsky C, Zaak D, Schmitt R, Hartmann A. Int J Oncol; 2002 May 15; 20(5):905-11. PubMed ID: 11956582 [Abstract] [Full Text] [Related]
9. Genetic and epigenetic alterations of the APC gene in malignant melanoma. Worm J, Christensen C, Grønbaek K, Tulchinsky E, Guldberg P. Oncogene; 2004 Jul 01; 23(30):5215-26. PubMed ID: 15133491 [Abstract] [Full Text] [Related]
10. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma. Li Z, Ren Y, Lin SX, Liang YJ, Liang HZ. Chin Med J (Engl); 2004 Aug 01; 117(8):1232-9. PubMed ID: 15361301 [Abstract] [Full Text] [Related]
11. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes. Prange W, Breuhahn K, Fischer F, Zilkens C, Pietsch T, Petmecky K, Eilers R, Dienes HP, Schirmacher P. J Pathol; 2003 Oct 01; 201(2):250-9. PubMed ID: 14517842 [Abstract] [Full Text] [Related]
12. Dysregulation of the Wnt/beta-catenin signaling pathway in canine cutaneous melanotic tumor. Han JI, Kim DY, Na KJ. Vet Pathol; 2010 Mar 01; 47(2):285-91. PubMed ID: 20139375 [Abstract] [Full Text] [Related]
13. Expression of the E-cadherin-catenin complex in lung neuroendocrine tumours. Clavel CE, Nollet F, Berx G, Tejpar S, Nawrocki-Raby B, Kaplan HH, van Roy FM, Birembaut PL. J Pathol; 2001 May 01; 194(1):20-6. PubMed ID: 11329137 [Abstract] [Full Text] [Related]
14. Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach. Kim HS, Hong EK, Park SY, Kim WH, Lee HS. Anticancer Res; 2003 May 01; 23(3C):2863-8. PubMed ID: 12926124 [Abstract] [Full Text] [Related]
15. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Wei Y, Van Nhieu JT, Prigent S, Srivatanakul P, Tiollais P, Buendia MA. Hepatology; 2002 Sep 01; 36(3):692-701. PubMed ID: 12198663 [Abstract] [Full Text] [Related]
16. Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Palacios J, Gamallo C. Cancer Res; 1998 Apr 01; 58(7):1344-7. PubMed ID: 9537226 [Abstract] [Full Text] [Related]
17. beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis. Saegusa M, Hashimura M, Yoshida T, Okayasu I. Br J Cancer; 2001 Jan 01; 84(2):209-17. PubMed ID: 11161379 [Abstract] [Full Text] [Related]
18. Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer. Shiina H, Igawa M, Urakami S, Shigeno K, Yoneda T, Terashima M, Deguchi M, Ribeiro-Filho L, Dahiya R. Cancer Res; 2001 Oct 01; 61(19):7101-9. PubMed ID: 11585741 [Abstract] [Full Text] [Related]
19. Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations. Bilim V, Kawasaki T, Katagiri A, Wakatsuki S, Takahashi K, Tomita Y. Clin Cancer Res; 2000 Feb 01; 6(2):460-6. PubMed ID: 10690524 [Abstract] [Full Text] [Related]
20. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules. Nakatani Y, Masudo K, Miyagi Y, Inayama Y, Kawano N, Tanaka Y, Kato K, Ito T, Kitamura H, Nagashima Y, Yamanaka S, Nakamura N, Sano J, Ogawa N, Ishiwa N, Notohara K, Resl M, Mark EJ. Mod Pathol; 2002 Jun 01; 15(6):617-24. PubMed ID: 12065775 [Abstract] [Full Text] [Related] Page: [Next] [New Search]